INNORPHA is a Tunisian health-tech startup founded by Dr. Lilia Romdhane.

The company was established to develop PREMEDIT, a specialized platform designed to accelerate the diagnosis of rare genetic diseases and identify repurposed drugs. The initiative was sparked by a study that identified 589 rare hereditary diseases in Tunisia, an under-represented population, aiming to provide precise and comprehensive data to facilitate patient treatment.